BAM Capital »

Eli Lilly & Co. shares owned by BAM Capital

Quarter-by-quarter ownership of Eli Lilly & Co. (LLY) shares owned by BAM Capital from 13F filings

Historical chart of BAM Capital investment in Eli Lilly & Co.

Tip: Access up to 7 years of quarterly data

All positions including Eli Lilly & Co. held by BAM Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eli Lilly & Co. by BAM Capital

Quarter filed Position value Share count Share price at filing
2011-09-30 $285k 7.7k 37.01
2011-06-30 $289k 7.7k 37.53

More positions owned by BAM Capital

Spdr S&p 500 Etf (SPY)
Pharmasset
iShares Russell 2000 Index (IWM)
Biogen Idec (BIIB)
Targacept
Netflix (NFLX)
Medivation
Keryx Biopharmaceuticals
Vivus
Barclays Bk Plc ipth s^p vix
Elan Corporation
Research In Motion
Delcath Sys
Delcath Sys
Acorda Therapeutics

View all positions for BAM Capital

Top funds holding Eli Lilly & Co.

Lilly Endowment
Vanguard Group
BlackRock
Pnc Financial Services
State Street Corporation
Capital Research Global Investors
FMR
Geode Capital Management
Capital World Investors
Morgan Stanley
Wellington Management Company
State Farm Mutual Automobile Insurance Company
PRIMECAP Management Company
Jpmorgan Chase & Co
Capital Research and Management Company - Division 3

View all funds holding Eli Lilly & Co.